Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
5
×
boston blog main
boston top stories
crispr
5
×
life sciences
national blog main
biotech
editas medicine
gene editing
national top stories
allergan
clinical trials
cynthia collins
deals
drugs
san francisco blog main
abbvie
alzheimer's disease
beam therapeutics
biotech week boston
bristol-myers squibb
broad institute
bwb
cancer
cindy perettie
cystic fibrosis
cystic fibrosis foundation
david liu
david walt
diagnostics
fda
feng zhang
foundation medicine
gilead sciences
hepatitis c
illumina
immuno-oncology
incivek
jeff leiden
jennifer doudna
What
editing
gene
medicines
crispr
editas
experimental
medicine
abbvie
allergan
alliance
benefiting
bio
biotech
blessing
bosley
boston
ceo
cf
check
clinical
coming
create
crisis
cusp
cystic
depart
developer
diagnostic
diagnostics
diseases
exits
fibrosis
fix
force
genetic
glimcher
groundbreaking
headline
heats
helped
Language
unknown
unset
Current search:
boston
×
crispr
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
